{"id":7976,"date":"2025-12-22T15:31:14","date_gmt":"2025-12-22T06:31:14","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4516\/"},"modified":"2026-08-16T13:47:37","modified_gmt":"2026-08-16T04:47:37","slug":"company-4516","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4516\/","title":{"rendered":"NIPPON SHINYAKU CO"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4516","DATE":"2025-12-22","longName":"Nippon Shinyaku Co., Ltd.","company_name_ja":"","fullTimeEmployees":2309,"address":"","phone":"","website":"https:\/\/www.nippon-shinyaku.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":5983,"financialCurrency":"","marketCap":403259,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":441,"epsForward":0,"bookValue":0,"totalRevenue":170771000000,"OperatingIncome":35498000000,"operatingMargins":20.789999999999999,"NetIncome":29721000000,"profitMargins":17.399999999999999,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":10.19,"recommendationMean":3.125,"recommendationKey":"hold","targetMeanPrice":4318.75,"numberOfAnalystOpinions":7,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:52:51.073307\", \"ticker\": \"4516\", \"ticker_full\": \"4516.T\", \"company_name\": \"NIPPON SHINYAKU CO\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"3\", \"strong_buy\": 2, \"buy\": 2, \"hold\": 2, \"sell\": 1, \"strong_sell\": 0, \"total_analysts\": 7, \"recommendation_key\": \"hold\", \"recommendation_mean\": 3.125}, \"target_prices\": {\"has_data\": true, \"current\": 3400.0, \"high\": 8600.0, \"low\": 2600.0, \"mean\": 4318.75, \"median\": 3825.0}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": {\"date\": \"2026-08-06\", \"eps_estimate\": 84.91, \"eps_actual\": null, \"surprise_pct\": null}, \"future_count\": 1, \"past_earnings\": [{\"date\": \"2026-02-08\", \"eps_estimate\": 70.0, \"eps_actual\": 149.62, \"surprise_pct\": 113.74}, {\"date\": \"2025-11-13\", \"eps_estimate\": 93.09, \"eps_actual\": 111.36, \"surprise_pct\": 19.62}, {\"date\": \"2025-08-06\", \"eps_estimate\": 84.91, \"eps_actual\": 122.52, \"surprise_pct\": 44.3}, {\"date\": \"2025-05-07\", \"eps_estimate\": 33.74, \"eps_actual\": 59.47, \"surprise_pct\": 76.26}, {\"date\": \"2025-02-06\", \"eps_estimate\": 131.88, \"eps_actual\": 180.84, \"surprise_pct\": 37.13}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 4.67, \"institution_pct\": 47.5, \"major_holders\": [{\"label\": \"\", \"value\": 4.67}, {\"label\": \"\", \"value\": 47.5}, {\"label\": \"\", \"value\": 49.83}, {\"label\": \"\", \"value\": 131.0}], \"institutional_holders\": [{\"holder\": \"VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund\", \"shares\": 845713, \"date_reported\": \"2026-04-30\", \"pct_held\": 1.2, \"pct_change\": 5.24, \"value\": 2875424200}, {\"holder\": \"Goldman Sachs TRT-Goldman Sachs Intl Small Cap Insights Fd.\", \"shares\": 835300, \"date_reported\": \"2026-04-30\", \"pct_held\": 1.19, \"pct_change\": 1.72, \"value\": 2840020000}, {\"holder\": \"VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund\", \"shares\": 566512, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.81, \"pct_change\": 7.07, \"value\": 1926140800}, {\"holder\": \"Victory Portfolios-Victory Trivalent International Small-Cap Fund\", \"shares\": 386200, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.55, \"pct_change\": -0.05, \"value\": 1313080000}, {\"holder\": \"iShares Trust-iShares Core MSCI EAFE ETF\", \"shares\": 385800, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.55, \"pct_change\": 0.0, \"value\": 1311720000}, {\"holder\": \"American Century ETF Trust-Avantis International Small Cap Value ETF\", \"shares\": 339200, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.48, \"pct_change\": -30.66, \"value\": 1153280000}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 244500, \"date_reported\": \"2026-04-30\", \"pct_held\": 0.35, \"pct_change\": 0.0, \"value\": 831300000}, {\"holder\": \"iShares Trust-iShares MSCI EAFE Small-Cap ETF\", \"shares\": 212300, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.3, \"pct_change\": -0.19, \"value\": 721820000}, {\"holder\": \"JNL Series Trust-JNL Multi-Manager International Small Cap Fund\", \"shares\": 184800, \"date_reported\": \"2026-03-31\", \"pct_held\": 0.26, \"pct_change\": 2.79, \"value\": 628320000}, {\"holder\": \"WisdomTree Trust-WisdomTree Japan Hedged Equity Fund\", \"shares\": 166800, \"date_reported\": \"2026-06-30\", \"pct_held\": 0.24, \"pct_change\": 20.0, \"value\": 567120000}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I\/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and Regenex Bio Inc. to develop RGX-121 and RGX-111 for the treatment of mucopolysaccharidosis type I and II. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":62,"get_dividend_history_year2":124,"get_dividend_history_year3":124,"get_dividend_history_year4":119,"get_dividend_history_year5":116,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-16T02:55:32.518744\", \"ticker\": \"4516\", \"ticker_full\": \"4516.T\", \"company_name\": \"NIPPON SHINYAKU CO\", \"company_info\": {\"name_en\": \"NIPPON SHINYAKU CO\", \"long_name\": \"Nippon Shinyaku Co., Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.nippon-shinyaku.co.jp\", \"employees\": 2309, \"country\": \"Japan\", \"city\": \"Kyoto\", \"address\": \"14, Nishinosho-Monguchi-cho\", \"description\": \"Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan, Europe, Switzerland, the United States, and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Atthena Therapeutics, Inc. to develop ATSN-101 that is in Phase I\/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and Regenex Bio Inc. to develop RGX-121 and RGX-111 for the treatment of mucopolysaccharidosis type I and II. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 3606.2, \"deviation\": 0.94, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 3778.88, \"deviation\": -3.68, \"trend\": \"down\"}, \"ma_75\": {\"ma_value\": 4044.25, \"deviation\": -10.0, \"trend\": \"down\"}, \"ma_200\": {\"ma_value\": 4517.86, \"deviation\": -19.43, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 170771000000.0, \"revenue_fmt\": \"\u00a51708\u5104\", \"gross_profit\": 113311000000.0, \"gross_profit_fmt\": \"\u00a51133\u5104\", \"operating_income\": 35498000000.0, \"operating_income_fmt\": \"\u00a5355\u5104\", \"ebit\": 36628000000.0, \"ebit_fmt\": \"\u00a5366\u5104\", \"net_income\": 29721000000.0, \"net_income_fmt\": \"\u00a5297\u5104\", \"eps\": 441.0, \"operating_margin\": 20.79, \"total_assets\": 346359000000.0, \"total_assets_fmt\": \"\u00a53464\u5104\", \"total_equity\": 291550000000.0, \"total_equity_fmt\": \"\u00a52916\u5104\", \"total_debt\": 2567000000.0, \"total_debt_fmt\": \"\u00a526\u5104\", \"total_cash\": 76592000000.0, \"total_cash_fmt\": \"\u00a5766\u5104\", \"equity_ratio\": 84.18, \"de_ratio\": 0.01, \"current_ratio\": 4.35, \"operating_cf\": 27221000000.0, \"operating_cf_fmt\": \"\u00a5272\u5104\", \"investing_cf\": 1982000000.0, \"investing_cf_fmt\": \"\u00a520\u5104\", \"financing_cf\": -9926000000.0, \"financing_cf_fmt\": \"-\u00a599\u5104\", \"free_cf\": 23439000000.0, \"free_cf_fmt\": \"\u00a5234\u5104\", \"net_margin\": 17.4, \"roe\": 10.19, \"roa\": 8.58}, {\"year\": 2025, \"revenue\": 160232000000.0, \"revenue_fmt\": \"\u00a51602\u5104\", \"gross_profit\": 109115000000.0, \"gross_profit_fmt\": \"\u00a51091\u5104\", \"operating_income\": 35451000000.0, \"operating_income_fmt\": \"\u00a5355\u5104\", \"ebit\": 36280000000.0, \"ebit_fmt\": \"\u00a5363\u5104\", \"net_income\": 32558000000.0, \"net_income_fmt\": \"\u00a5326\u5104\", \"eps\": 483.26, \"operating_margin\": 22.12, \"total_assets\": 283637000000.0, \"total_assets_fmt\": \"\u00a52836\u5104\", \"total_equity\": 247027000000.0, \"total_equity_fmt\": \"\u00a52470\u5104\", \"total_debt\": 2722000000.0, \"total_debt_fmt\": \"\u00a527\u5104\", \"total_cash\": 55241000000.0, \"total_cash_fmt\": \"\u00a5552\u5104\", \"equity_ratio\": 87.09, \"de_ratio\": 0.01, \"current_ratio\": 4.94, \"operating_cf\": 36126000000.0, \"operating_cf_fmt\": \"\u00a5361\u5104\", \"investing_cf\": -28877000000.0, \"investing_cf_fmt\": \"-\u00a5289\u5104\", \"financing_cf\": -9902000000.0, \"financing_cf_fmt\": \"-\u00a599\u5104\", \"free_cf\": 1333000000.0, \"free_cf_fmt\": \"\u00a513\u5104\", \"net_margin\": 20.32, \"roe\": 13.18, \"roa\": 11.48}, {\"year\": 2024, \"revenue\": 148255000000.0, \"revenue_fmt\": \"\u00a51483\u5104\", \"gross_profit\": 98021000000.0, \"gross_profit_fmt\": \"\u00a5980\u5104\", \"operating_income\": 33297000000.0, \"operating_income_fmt\": \"\u00a5333\u5104\", \"ebit\": 33945000000.0, \"ebit_fmt\": \"\u00a5339\u5104\", \"net_income\": 25851000000.0, \"net_income_fmt\": \"\u00a5259\u5104\", \"eps\": 383.82, \"operating_margin\": 22.46, \"total_assets\": 263404000000.0, \"total_assets_fmt\": \"\u00a52634\u5104\", \"total_equity\": 220224000000.0, \"total_equity_fmt\": \"\u00a52202\u5104\", \"total_debt\": 2872000000.0, \"total_debt_fmt\": \"\u00a529\u5104\", \"total_cash\": 58094000000.0, \"total_cash_fmt\": \"\u00a5581\u5104\", \"equity_ratio\": 83.61, \"de_ratio\": 0.01, \"current_ratio\": 4.4, \"operating_cf\": 16289000000.0, \"operating_cf_fmt\": \"\u00a5163\u5104\", \"investing_cf\": -9921000000.0, \"investing_cf_fmt\": \"-\u00a599\u5104\", \"financing_cf\": -9719000000.0, \"financing_cf_fmt\": \"-\u00a597\u5104\", \"free_cf\": 6640000000.0, \"free_cf_fmt\": \"\u00a566\u5104\", \"net_margin\": 17.44, \"roe\": 11.74, \"roa\": 9.81}, {\"year\": 2023, \"revenue\": 144175000000.0, \"revenue_fmt\": \"\u00a51442\u5104\", \"gross_profit\": 88195000000.0, \"gross_profit_fmt\": \"\u00a5882\u5104\", \"operating_income\": 30050000000.0, \"operating_income_fmt\": \"\u00a5300\u5104\", \"ebit\": 30625000000.0, \"ebit_fmt\": \"\u00a5306\u5104\", \"net_income\": 22812000000.0, \"net_income_fmt\": \"\u00a5228\u5104\", \"eps\": 338.7, \"operating_margin\": 20.84, \"total_assets\": 237451000000.0, \"total_assets_fmt\": \"\u00a52375\u5104\", \"total_equity\": 195624000000.0, \"total_equity_fmt\": \"\u00a51956\u5104\", \"total_debt\": 2664000000.0, \"total_debt_fmt\": \"\u00a527\u5104\", \"total_cash\": 60047000000.0, \"total_cash_fmt\": \"\u00a5600\u5104\", \"equity_ratio\": 82.38, \"de_ratio\": 0.01, \"current_ratio\": 4.49, \"operating_cf\": 26170000000.0, \"operating_cf_fmt\": \"\u00a5262\u5104\", \"investing_cf\": -17631000000.0, \"investing_cf_fmt\": \"-\u00a5176\u5104\", \"financing_cf\": -9605000000.0, \"financing_cf_fmt\": \"-\u00a596\u5104\", \"free_cf\": 14442000000.0, \"free_cf_fmt\": \"\u00a5144\u5104\", \"net_margin\": 15.82, \"roe\": 11.66, \"roa\": 9.61}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2022, \"amount\": 116.0}, {\"year\": 2023, \"amount\": 119.0}, {\"year\": 2024, \"amount\": 124.0}, {\"year\": 2025, \"amount\": 124.0}, {\"year\": 2026, \"amount\": 62.0}], \"latest\": 62.0, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-7976","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NIPPON SHINYAKU CO - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4516\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4516\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4516\/\",\"name\":\"NIPPON SHINYAKU CO - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2025-12-22T06:31:14+00:00\",\"dateModified\":\"2026-08-16T04:47:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4516\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4516\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4516\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NIPPON SHINYAKU CO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NIPPON SHINYAKU CO - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4516\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4516\/","url":"https:\/\/japanir.jp\/en\/company\/company-4516\/","name":"NIPPON SHINYAKU CO - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2025-12-22T06:31:14+00:00","dateModified":"2026-08-16T04:47:37+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4516\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4516\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4516\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"NIPPON SHINYAKU CO"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/7976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=7976"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=7976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}